Bridgepoint, a private equity firm, completed the acquisition of Identicare, a UK-based pet microchipping and pet owner-focused services company, from Animalcare Group, a UK-based pharmaceuticals business, for £25m. "The disposal of Identicare significantly strengthens the balance sheet of the Animalcare Group and enables us to accelerate our organic and inorganic growth initiatives and deliver long-term value creation for shareholders. We continue to see a large number of opportunities and this transaction increases our confidence in being able to execute on that pipeline," Animalcare.